These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23141897)

  • 1. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
    Toriyabe N; Hayashi Y; Harashima H
    Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
    Nakamura Y; Kogure K; Futaki S; Harashima H
    J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
    Khalil IA; Hayashi Y; Mizuno R; Harashima H
    J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
    Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2011 Jan; 149(1):58-64. PubMed ID: 20826039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ornithine and tryptophan analogs as efficient polycations for short interference RNA delivery to tumor cells.
    Sato Y; Hatakeyama H; Harashima H
    Biol Pharm Bull; 2010; 33(7):1246-9. PubMed ID: 20606322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.
    Moriguchi R; Kogure K; Akita H; Futaki S; Miyagishi M; Taira K; Harashima H
    Int J Pharm; 2005 Sep; 301(1-2):277-85. PubMed ID: 16019173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
    Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
    Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y; Hashida M; Harashima H
    Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
    Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
    Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
    Golan M; Feinshtein V; David A
    Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
    Wan Y; Moyle PM; Gn PZ; Toth I
    Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis.
    Hayashi Y; Mizuno R; Ikramy KA; Akita H; Harashima H
    Nucleic Acid Ther; 2012 Oct; 22(5):360-3. PubMed ID: 22963044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
    Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
    Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles.
    Akita H; Ishii S; Miura N; Shaheen SM; Hayashi Y; Nakamura T; Kaji N; Baba Y; Harashima H
    Biomaterials; 2013 Nov; 34(35):8979-90. PubMed ID: 23968857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
    Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
    Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
    Kogure K
    Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.